Therapeutic interference with PDGF-BB/PDGFR-β and TNF-α/LT-β mediated FDC differentiation and rheumatoid synovitis offers novel opportunities for patients suffering from aggressive/therapeutically resistant forms of RA. This evidence concerns the gene LTB and rheumatoid arthritis.